New findings about the drug’s safety and efficacy from a phase II trial
Data from Phase 2 study of ONC201 to be presented at ASCO
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy